Belgian biotech Apaxen appoints Bart Wuurman as CEO
Retrieved on:
Thursday, November 12, 2020
Bart Wuurman is an accomplished biotech CEO with over 30 years' experience in innovative drug development, biotech financing, business development and licensing.
Key Points:
- Bart Wuurman is an accomplished biotech CEO with over 30 years' experience in innovative drug development, biotech financing, business development and licensing.
- Bart was instrumental to successful biotech company exits in the UK and in the Netherlands.
- Lotfi Yelles Chaouche, Apaxen Board member and partner at Theodorus, commented:
"We are very pleased to have found a CEO for Apaxen with the caliber of Bart Wuurman. - Bart Wuurman succeeds Jol Crouzet, PhD as CEO, who has accepted another appointment.